female BALB/c nude mice (n=5 per group). The growth and weight of xenograft tumors were detected one month later. In experimental metastasis studies, tail vein injection of tumor cells (4×10 6 ) was performed in blindly randomized four-week-old female BALB/c nude mice (n=5 per group). For in vivo therapeutic studies, tumor cells (1×10 6 or 0.4×10 6 ) were injected into dorsal flanks or tail vein of nude mice, respectively. One week after tumor cell inoculation, mice were blindly randomized and treated by intratumoral or tail vein injection of lentivirus-mediated shRNA (1×10 7 plaque-forming units in 100 μl PBS) or synthesized cell-penetrating peptide (ChinaPeptides Co. Ltd) as indicated. Tumor volume and survival time of each mouse were monitored and recorded. The animals were imaged using In-Vivo Xtreme II small animal imaging system (Bruker Corporation, Billerica, MA) .
Patient tissue samples:
The Institutional Review Board of Tongji Medical College approved the human tissue study (approval number: 2011-S085). All procedures were carried out in accordance with approved guidelines. Written informed consent was obtained from all legal guardians of patients. The NB tissues were obtained during surgery at Union Hospital of Tongji medical College. Patients with a history of preoperative chemotherapy or radiotherapy were excluded. Human normal dorsal root ganglia tissues were collected from therapeutic abortion. All fresh specimens were frozen in liquid nitrogen, validated by pathological diagnosis, and stored at -80°C until use.
Amino acid profiling:
For each sample, 30 mg of tissue was homogenized with zirconia beads at 30 Hz for 3 min, ultrasonicated for 10 min, and centrifugated at 4°C and 16000 g for 15 min. The supernatant was applied to analyze concentrations of amino acids, which was performed by an Agilent 1290 ultra-high performance liquid chromatography (UHPLC) system coupled to an Agilent 6470A Triple Quadrupole MS System (Agilent Technologies, Santa Clara, CA). A Waters BEH Amide column (100 mm × 2.1mm, 1.7 μm) was used for amino compound separation with a flow rate at 0.35 ml/min and column temperature at 55°C. The mobile phase consisted of (A) 10 mM ammonium formate in water, 0.2% formic acid, and 0.08 mM phthalic acid, (B) acetonitrile with 2 mM ammonium formate, 0.2% formic acid, and 0.08 mM phthalic acid. The chromatographic separation was conducted by a gradient elution program as follows: 1 min, 85% B; 4 min, 82% B; 7 min, 60% B; 8 min, 50% B and held to 9 min; 9.1 min, 85% B and held to 12 min. Multiple Reaction Monitoring (MRM) was used to monitor amino acid compounds. All amino acid standards were purchased from Alfa-aesar (Tewksbury, MA). The Agilent MassHunter Quantitation Analysis (version B08) was applied to analyze data.
Data availability: RNA-seq data supporting the results of this study have been deposited in GEO database (https://www.ncbi.nlm.nih.gov/geo/), under accession number GSE133009. Public datasets are available from GEO database (GSE16476, GSE62564, GSE1084, and GSE9891) or TCGA database. All remaining data are presented within the article and Supporting Information Files, and available from the corresponding author upon request. Figure S1 . MZF1 facilitates the expression of proline synthetic genes in NB. A) Representative images (left panel) and quantification (right panel) of colony formation assay revealing the growth of SH-SY5Y and IMR-32 cells cultured in DMEM lacking non-essential amino acids, without or with supplementation of L-aspartic acid (Asp, 1 mM), L-glutamic acid (Glu, 1 mM), or proline (Pro, 3 mM). B) Western blot assay indicating the MZF1 levels in normal dorsal root ganglia (DG) and NB cell lines. C and D) Real-time qRT-PCR (C, normalized to β-actin, n=4) and western blot (D) assays showing the expression of MZF1, ALDH18A1, ODC1, PYCR1, SLC7A5, or VARS in SK-N-AS and BE(2)-C cells stably transfected with empty vector (mock), MZF1, scramble shRNA (sh-Scb), sh-MZF1 #1, or sh-MZF1 #2. E and F) Real-time qRT-PCR (E, normalized to β-actin, n=4) and western blot (F) assays indicating the levels of MZF1, ALDH18A1 and PYCR1 in colon cancer SW480 cells and cervical cancer SiHa cells transfected with mock, MZF1, sh-Scb, sh-MZF1 #1, or sh-MZF1 #2. G and H) Real-time qRT-PCR (G, normalized to β-actin, n=4) and western blot (H) assays showing the levels of proline synthetic and catabolism genes PYCR2, PYCR3, PRODH, or P5CDH in SH-SY5Y and IMR-32 cells stably transfected with mock, MZF1, sh-Scb, sh-MZF1 #1, or sh-MZF1 #2. Student's t test compared difference in A, C, E and G. * P<0.05, ** P<0.01 vs. DMEM, mock, or sh-Scb. Data are shown as mean ± s.e.m. (error bars) and representative of three independent experiments in A-H. 
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